Cargando…
Colorectal cancer survival rates in Makassar, Eastern Indonesia: A retrospective Cohort Study
BACKGROUND: The 5-year overall survival (OS) rate for colorectal cancer (CRC) has been reported as 39%, and the 5-year recurrence-free survival (RFS) rate has been reported as 14%. Various prognostic factors have been associated with differences in survival rates among CRC patients. This study inves...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760491/ https://www.ncbi.nlm.nih.gov/pubmed/35059192 http://dx.doi.org/10.1016/j.amsu.2021.103211 |
_version_ | 1784633331294404608 |
---|---|
author | Labeda, Ibrahim Lusikooy, Ronald Erasio Mappincara Dani, Muhammad Iwan Sampetoding, Samuel Kusuma, Muhammad Ihwan Uwuratuw, Julianus Aboyaman Syarifuddin, Erwin Arsyad, Arham Faruk, Muhammad |
author_facet | Labeda, Ibrahim Lusikooy, Ronald Erasio Mappincara Dani, Muhammad Iwan Sampetoding, Samuel Kusuma, Muhammad Ihwan Uwuratuw, Julianus Aboyaman Syarifuddin, Erwin Arsyad, Arham Faruk, Muhammad |
author_sort | Labeda, Ibrahim |
collection | PubMed |
description | BACKGROUND: The 5-year overall survival (OS) rate for colorectal cancer (CRC) has been reported as 39%, and the 5-year recurrence-free survival (RFS) rate has been reported as 14%. Various prognostic factors have been associated with differences in survival rates among CRC patients. This study investigated the difference between several prognostic factors and the OS and RFS rates of CRC patients at the Dr. Wahidin Sudirohusodo General Hospital Makassar in Indonesia. MATERIALS AND METHODS: The study group comprised all CRC patients treated at the Division of Digestive Surgery from 2014 to 2016. Prognostic factor data were collected from medical records for 293 patients. The OS and RFS rates were analyzed using the bivariate Kaplan–Meier method and log-rank tests. RESULTS: Log-rank analysis of the association of age, histopathology, stage, definitive surgery, chemotherapy, and radiotherapy with the OS rate showed p-values of 0.031, 0.009, 0.014, 0.000, 0.343, and 0.381, respectively. Log-rank analysis of the association of these prognostic factors with the RFS rate showed p-values of 0.282, 0.006, 0.008, 0.020, 0.002, and 0.000, respectively. CONCLUSION: There were significant differences in the OS rate according to age, histopathology, stage, and history of definitive surgery. Histopathology, stage, history of definitive surgery, and chemotherapy and radiotherapy were significantly associated with differences in the RFS rate. |
format | Online Article Text |
id | pubmed-8760491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87604912022-01-19 Colorectal cancer survival rates in Makassar, Eastern Indonesia: A retrospective Cohort Study Labeda, Ibrahim Lusikooy, Ronald Erasio Mappincara Dani, Muhammad Iwan Sampetoding, Samuel Kusuma, Muhammad Ihwan Uwuratuw, Julianus Aboyaman Syarifuddin, Erwin Arsyad, Arham Faruk, Muhammad Ann Med Surg (Lond) Cohort Study BACKGROUND: The 5-year overall survival (OS) rate for colorectal cancer (CRC) has been reported as 39%, and the 5-year recurrence-free survival (RFS) rate has been reported as 14%. Various prognostic factors have been associated with differences in survival rates among CRC patients. This study investigated the difference between several prognostic factors and the OS and RFS rates of CRC patients at the Dr. Wahidin Sudirohusodo General Hospital Makassar in Indonesia. MATERIALS AND METHODS: The study group comprised all CRC patients treated at the Division of Digestive Surgery from 2014 to 2016. Prognostic factor data were collected from medical records for 293 patients. The OS and RFS rates were analyzed using the bivariate Kaplan–Meier method and log-rank tests. RESULTS: Log-rank analysis of the association of age, histopathology, stage, definitive surgery, chemotherapy, and radiotherapy with the OS rate showed p-values of 0.031, 0.009, 0.014, 0.000, 0.343, and 0.381, respectively. Log-rank analysis of the association of these prognostic factors with the RFS rate showed p-values of 0.282, 0.006, 0.008, 0.020, 0.002, and 0.000, respectively. CONCLUSION: There were significant differences in the OS rate according to age, histopathology, stage, and history of definitive surgery. Histopathology, stage, history of definitive surgery, and chemotherapy and radiotherapy were significantly associated with differences in the RFS rate. Elsevier 2021-12-30 /pmc/articles/PMC8760491/ /pubmed/35059192 http://dx.doi.org/10.1016/j.amsu.2021.103211 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Cohort Study Labeda, Ibrahim Lusikooy, Ronald Erasio Mappincara Dani, Muhammad Iwan Sampetoding, Samuel Kusuma, Muhammad Ihwan Uwuratuw, Julianus Aboyaman Syarifuddin, Erwin Arsyad, Arham Faruk, Muhammad Colorectal cancer survival rates in Makassar, Eastern Indonesia: A retrospective Cohort Study |
title | Colorectal cancer survival rates in Makassar, Eastern Indonesia: A retrospective Cohort Study |
title_full | Colorectal cancer survival rates in Makassar, Eastern Indonesia: A retrospective Cohort Study |
title_fullStr | Colorectal cancer survival rates in Makassar, Eastern Indonesia: A retrospective Cohort Study |
title_full_unstemmed | Colorectal cancer survival rates in Makassar, Eastern Indonesia: A retrospective Cohort Study |
title_short | Colorectal cancer survival rates in Makassar, Eastern Indonesia: A retrospective Cohort Study |
title_sort | colorectal cancer survival rates in makassar, eastern indonesia: a retrospective cohort study |
topic | Cohort Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760491/ https://www.ncbi.nlm.nih.gov/pubmed/35059192 http://dx.doi.org/10.1016/j.amsu.2021.103211 |
work_keys_str_mv | AT labedaibrahim colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy AT lusikooyronalderasio colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy AT mappincara colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy AT danimuhammadiwan colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy AT sampetodingsamuel colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy AT kusumamuhammadihwan colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy AT uwuratuwjulianusaboyaman colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy AT syarifuddinerwin colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy AT arsyadarham colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy AT farukmuhammad colorectalcancersurvivalratesinmakassareasternindonesiaaretrospectivecohortstudy |